Background There are a number of instruments that describe severity and progression of
multiple sclerosis and they are increasingly used as endpoints to assess the effectiveness of …

Background Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous
system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of …

Книга посвящена вопросам использования опросников, тестов и шкал для оценки
состояния неврологических больных и определения эффективности лечения …

Due to the heterogeneous nature of the disease, it is a challenge to capture disease activity
of multiple sclerosis (MS) in a reliable and valid way. Therefore, it can be difficult to assess …

Background: Multiple sclerosis (MS) is a chronic neurologic disease associated with gait
impairment that adversely affects quality of life (QOL). Data are lacking on the impact of …

Abstract Changes in health policy have underlined the importance of evidence-based
clinical practice and rigorous evaluation of patient-based outcomes. As patient-based …

Objective To gain insights into NMOSD disease impact, which may negatively affect QoL of
patients, their families, and social network. Methods The current study used validated …

Quality of Life (QOL) is impaired in multiple sclerosis (MS) in part due to physical disability.
MS-associated fatigue (MSF) and depression (MSD) are common and treatable features of …

Background MS symptoms affect many functional domains. Knowing the specific impact of
symptoms on health-related quality of life (HRQoL) is vital for successful disease and …

Health-related quality of life (HRQoL) has been more intensively studied in multiple sclerosis
(MS) than in any other neurological disorder. Traditional medical models of impairment and …